(Q52728409)

6 May 2018

title

TBX3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57KIP2 repression. (English)

1 reference

6 May 2018

main subject

papillary thyroid cancer

1 reference

Xiaomeng Li

1

1 reference

6 May 2018

Xianhui Ruan

2

1 reference

6 May 2018

Peitao Zhang

3

1 reference

6 May 2018

Yang Yu

4

1 reference

6 May 2018

Ming Gao

5

1 reference

6 May 2018

Shukai Yuan

6

1 reference

6 May 2018

Zewei Zhao

7

1 reference

6 May 2018

Jie Yang

8

1 reference

6 May 2018

Li Zhao

9

1 reference

6 May 2018

language of work or name

English

0 references

publication date

7 March 2018

1 reference

6 May 2018

published in

Oncogene

1 reference

6 May 2018

https://scigraph.springernature.com/pub.10.1038/s41388-017-0090-2

exact match

0 references

cites work

Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

The T-box transcription factors TBX2 and TBX3 in mammary gland development and breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

Inhibition of Sox2-dependent activation of Shh in the ventral diencephalon by Tbx3 is required for formation of the neurohypophysis

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

TBX3 and its isoform TBX3+2a are functionally distinctive in inhibition of senescence and are overexpressed in a subset of breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

Increased expression of cSHMT, Tbx3 and utrophin in plasma of ovarian and breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

Tbx3 fosters pancreatic cancer growth by increased angiogenesis and activin/nodal-dependent induction of stemness.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

Tbx3 represses E-cadherin expression and enhances melanoma invasiveness.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

The T-Box factor TBX3 is important in S-phase and is regulated by c-Myc and cyclin A-CDK2

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

The oncogenic TBX3 is a downstream target and mediator of the TGF-β1 signaling pathway

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

TBX3, the gene mutated in ulnar-mammary syndrome, promotes growth of mammary epithelial cells via repression of p19ARF, independently of p53.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

The T-box transcription factor TBX3 drives proliferation by direct repression of the p21(WAF1) cyclin-dependent kinase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

Tbx3 represses PTEN and is over-expressed in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

Papillary thyroid carcinoma variants

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

Long Intergenic Noncoding RNA 00511 Acts as an Oncogene in Non-small-cell Lung Cancer by Binding to EZH2 and Suppressing p57.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith–Wiedemann syndrome

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

Expression of the components of the Cip/Kip family in malignant lymphoma of the thyroid.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

Imprinting disruption of the CDKN1C/KCNQ1OT1 domain: the molecular mechanisms causing Beckwith-Wiedemann syndrome and cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

p57(Kip2) and cancer: time for a critical appraisal.

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2and c-Myc expression

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

Identification of a Tbx1/Tbx2/Tbx3 genetic pathway governing pharyngeal and arterial pole morphogenesis

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

Gene expression profiling at early organogenesis reveals both common and diverse mechanisms in foregut patterning

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

Disruption of SoxB1-dependent Sonic hedgehog expression in the hypothalamus causes septo-optic dysplasia

1 reference

https://api.crossref.org/works/10.1038%2FS41388-017-0090-2

7 January 2021

Loss of imprinting and genetic alterations of the cyclin-dependent kinase inhibitor p57KIP2 gene in head and neck squamous cell carcinoma

1 reference

12 December 2020

Expression of p57/Kip2 protein in normal and neoplastic thyroid tissues

1 reference

12 December 2020

Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas.

1 reference

12 December 2020

T-box transcription factors in cancer biology

1 reference

12 December 2020

Overexpression of Tbx3 is correlated with Epithelial-Mesenchymal Transition phenotype and predicts poor prognosis of colorectal cancer

1 reference

12 December 2020

10.1038/S41388-017-0090-2

Identifiers

DOI

1 reference

6 May 2018

PubMed ID

29511350

1 reference

6 May 2018